8-K: Ultralife Q2 Sales Up 13%, Profit Falls Amid Headwinds

Ultralife Corporation reported a 13% increase in second-quarter sales to $48.6 million, driven by an acquisition, but faced significant declines in profitability and Communications Systems sales.

Summary

• Total sales increased 13.0% to $48.6 million in Q2 2025 from $43.0 million in Q2 2024.
• Excluding the Electrochem acquisition, sales declined 8.7% to $39.3 million.
• Battery & Energy Products sales rose 25.0% to $45.9 million, primarily due to Electrochem, with organic sales being essentially flat.
• Communications Systems sales decreased 57.2% to $2.7 million due to delayed purchase orders.
• Gross profit remained flat at $11.6 million, but gross margin decreased to 23.9% from 26.9%.
• Operating income fell to $2.3 million from $3.9 million, with operating margin decreasing to 4.6% from 9.1%.
• GAAP EPS was $0.05, down from $0.18 in Q2 2024.
• Adjusted EBITDA was $4.1 million, down from $5.4 million in Q2 2024.
• Backlog of high-confidence orders decreased to $89 million from $95 million at the end of Q1 2025.
• Prepaid $2.7 million of acquisition debt, exceeding the quarterly amortization requirement by $2.0 million.

Sentiment

Score: 3

Explanation: The financial results for the quarter show significant declines in profitability metrics (EPS, operating income, EBITDA) and a substantial drop in a key segment's sales (Communications Systems), despite an overall revenue increase driven by acquisition. While management expresses optimism for the second half, the current performance indicates considerable headwinds and challenges.

Positives

• Overall revenue increased by 13.0% to $48.6 million, primarily driven by the Electrochem acquisition.
• Government/defense sales within Battery & Energy Products increased by 61.1%, reflecting strong demand from a U.S.-based global prime.
• Communications Systems gross margin improved to 28.4% from 25.6% year-over-year due to product mix.
• Prepaid $2.7 million of acquisition debt, which was $2.0 million more than the quarterly amortization requirement, strengthening the balance sheet.
• Continued investment in new product development, with several offerings advancing into validation and production.
• Cash balance increased to $10.941 million as of June 30, 2025, from $6.854 million as of December 31, 2024.

Negatives

• Organic sales, excluding Electrochem, declined by 8.7% to $39.3 million.
• Communications Systems sales significantly decreased by 57.2% to $2.7 million due to delayed purchase orders.
• Gross margin declined to 23.9% from 26.9% due to product mix, higher tariffs, freight costs, and lower factory throughput.
• Operating income decreased to $2.3 million from $3.9 million, and operating margin fell to 4.6% from 9.1%.
• GAAP EPS dropped to $0.05 from $0.18 in the prior year.
• Adjusted EBITDA decreased to $4.1 million from $5.4 million.
• Total backlog and high-confidence orders decreased to $89 million from $95 million reported for the first quarter of 2025.
• Commercial sales within Battery & Energy Products decreased by 20.4%, primarily due to declines in medical and oil & gas sales.
• Operating expenses increased by 22.2% to $9.3 million, partly due to one-time, non-recurring expenses and increased new product development costs.
• Other expense increased significantly to $1.1 million from $0.1 million, primarily due to interest expense from the Electrochem acquisition financing and foreign currency loss.

Risks

• Uncertain global economic conditions, including the impact of tariffs and inflation.
• Potential reductions in revenues from key customers.
• Delays or reductions in U.S. and foreign military spending.
• Challenges in achieving global acceptance of new products.
• Disruptions, delays, or material price increases in the supply of raw materials and components due to business conditions, new or additional tariffs, global conflicts, weather, or other uncontrollable factors.

Future Outlook

Management expects improved results in the second half of 2025 and into 2026, anticipating a rebound in the Communications Systems business, early purchase orders from new battery product programs, renewed demand from medical and oil & gas customers, sustained growth in global defense spending, and an expanding opportunity pipeline across both business segments.

Management Comments

• "The second quarter was a challenging period for Ultralife."
• "While the addition of Electrochem lifted revenue, Battery & Energy Products organic sales were essentially flat and Communications Systems sales declined due to delayed purchase orders."
• "We also faced headwinds from tariffs, unfavorable product mix shifts across our business and order timing, which collectively impacted gross profit."
• "Nevertheless, we continued to invest in new product development, with several offerings advancing into validation and production."
• "We also applied the proceeds from our Employee Retention Credit collected during the quarter to prepay some of our acquisition debt, paying down a total of $2.7 million, $2.0 million more than our quarterly debt amortization requirement."
• "Notwithstanding the challenges experienced in the second quarter, we expect improved results in the second half of the year and into 2026."
• "Our priorities remain converting long-term new product development efforts into revenue, advancing vertical integration in the oil & gas segment, and maintaining a strong focus on operational efficiency initiatives to deliver sustainable profitable growth and maximizing the value of our global brand."

Industry Context

The company operates in the power solutions, communications, and electronics systems markets, serving government/defense and commercial customers. The decline in commercial sales for medical and oil & gas suggests potential softness in those specific sub-sectors or increased competition, while strong government/defense demand aligns with broader global defense spending trends. The impact of tariffs and freight costs indicates ongoing global supply chain and trade challenges affecting manufacturing industries.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Negative impact due to significant decline in GAAP EPS and Adjusted EPS, and lower operating income and EBITDA. Backlog reduction also suggests potential future revenue challenges.
• Employees: No direct impact mentioned, but operational efficiency initiatives could imply future workforce adjustments.
• Customers: Delayed purchase orders in Communications Systems indicate potential dissatisfaction or shifting demand from some customers. Strong demand from a U.S.-based global prime in defense is positive for that customer segment.
• Suppliers: Potential for disruptions, delays, or price increases in raw materials and components could impact supplier relationships and costs.
• Creditors: Positive impact from the prepayment of $2.7 million in acquisition debt, exceeding amortization requirements, which strengthens the company's debt servicing capacity.

Next Steps

• Convert long-term new product development efforts into revenue.
• Advance vertical integration in the oil & gas segment.
• Maintain a strong focus on operational efficiency initiatives.
• Maximize the value of the global brand.
• Expect improved results in the second half of 2025 and into 2026.
• Expect Communications Systems business to rebound.
• Anticipate early purchase orders from long-term new product programs for the battery business.
• Anticipate a rebound in demand from medical and oil & gas customers.
• Anticipate sustained growth in global defense spending.
• Anticipate an expanding opportunity pipeline across both businesses.

Key Dates

Recommendation

While the quarter showed significant declines in profitability and a key segment, the overall revenue growth (albeit acquisition-driven) and management's clear articulation of challenges and a positive outlook for H2 2025 and 2026 suggest potential for recovery. The proactive debt reduction is also a positive sign. An investor might hold to see if the anticipated rebound in Communications Systems and new product orders materialize, rather than selling on current weakness, but the immediate results do not warrant a buy.

Keywords

Ultralife Corporation, ULBI, Q2 Earnings, Battery & Energy Products, Communications Systems, SEC Filing, Financial Results, Defense Spending, Medical Devices, Oil & Gas, Electrochem Acquisition, Adjusted EBITDA, GAAP EPS, Backlog, Debt Reduction, Tariffs, Supply Chain